Rosivo

Rosivo is a regenerative medicine company focused on developing innovative solutions for cartilage repair and regeneration. The company's technology is based on pioneering research in tissue engineering from the University of California, Davis, specifically targeting the treatment of focal cartilage lesions in the knee and other joints. Rosivo's primary goal is to produce functional, lab-grown cartilage tissue that can be implanted to restore joint function and prevent the progression of degenerative joint diseases like osteoarthritis. Their approach seeks to overcome the limitations of current surgical interventions by providing a biological replacement that mimics the properties of natural hyaline cartilage. By utilizing a proprietary scaffold-free process, the company aims to deliver high-quality tissue constructs that integrate effectively with host tissue.